Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07022496
PHASE4
Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals
Sponsor: Ain Shams University
View on ClinicalTrials.gov
Summary
Caffeine extracted from green tea to abort acute attack of Migraine
Official title: Assessment of Oral Caffeine Intake in Reducing the Severity of Acute Migraine Attack Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2023-04-26
Completion Date
2025-08
Last Updated
2025-06-15
Healthy Volunteers
No
Conditions
Interventions
DRUG
Caffeine (200 mg)
caffeine tablets
DRUG
triptans
Sumatriptan
DRUG
NSAID (Nonsteroidal anti-inflammatory drugs)
Aspirin 250 mg, 81 mg, 75 mg
DRUG
Paracetamol (acetaminophen)
Paracetamol 250 mg
Locations (1)
Ainshams university
Cairo, Egypt